Renal Cell Carcinoma
Showing NaN - NaN of 53
Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,
Completed
- Renal Cell Carcinoma
- Clear-cell Metastatic Renal Cell Carcinoma
- Nivolumab
- +3 more
-
Duarte, California
- +13 more
Nov 30, 2021
Renal Cell Carcinoma Trial in France, Spain, United States (BMS-936558 (Anti-PD-1))
Completed
- Renal Cell Carcinoma
- BMS-936558 (Anti-PD-1)
-
San Francisco, California
- +13 more
Oct 13, 2021
Renal Cell Carcinoma Trial in Boston (CyberKnife)
Recruiting
- Renal Cell Carcinoma
- CyberKnife
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Oct 6, 2021
Breast Cancer, Ovarian Cancer, Colorectal Cancer Trial in United States (Durvalumab, Tremelimumab)
Completed
- Breast Cancer
- +4 more
-
New Haven, Connecticut
- +5 more
Jul 13, 2021
Renal Cell Carcinoma Trial in Worldwide (Cabozantinib tablets, Everolimus (Afinitor) tablets)
Completed
- Renal Cell Carcinoma
- Cabozantinib tablets
- Everolimus (Afinitor) tablets
-
Birmingham, Alabama
- +204 more
Apr 1, 2021
Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Renal Cell Carcinoma Trial in Boston (GVAX)
Completed
- Sarcoma, Clear Cell
- +3 more
- GVAX
-
Boston, Massachusetts
- +1 more
Mar 2, 2021
Renal Cell Carcinoma, Renal Cancer Trial in Boston, Durham (Everolimus)
Completed
- Renal Cell Carcinoma
- Renal Cancer
-
Boston, Massachusetts
- +2 more
Feb 8, 2021
Advanced Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Boston, New York, Nashville
Completed
- Advanced Cancer
- +5 more
-
Boston, Massachusetts
- +3 more
Nov 24, 2020
Renal Cell Carcinoma Trial in Worldwide (TRC105 and Axitinib, Axitinib)
Terminated
- Renal Cell Carcinoma
- TRC105 and Axitinib
- Axitinib
-
Birmingham, Alabama
- +38 more
Oct 15, 2020
Renal Cell Carcinoma Trial in Boston (Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging)
Terminated
- Renal Cell Carcinoma
- Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging
-
Boston, Massachusetts
- +1 more
Jun 26, 2020
Renal Cell Carcinoma Trial in Boston (Arterial Spin Labeling Magnetic Resonance Imaging)
Completed
- Renal Cell Carcinoma
- Arterial Spin Labeling Magnetic Resonance Imaging
-
Boston, Massachusetts
- +1 more
Feb 24, 2020
Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody, Bevacizumab, Sunitinib)
Completed
- Renal Cell Carcinoma
- Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody
- +2 more
-
Scottsdale, Arizona
- +44 more
Dec 19, 2019
Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (Standard Treatment,
Terminated
- Advanced Renal Cell Carcinoma
- +2 more
- Standard Treatment
- AGS-003
-
Scottsdale, Arizona
- +124 more
Jun 13, 2018
Renal Cell Carcinoma, Kidney Cancer Trial in Boston, Nashville (bevacizumab, temsirolimus)
Completed
- Renal Cell Carcinoma
- Kidney Cancer
-
Boston, Massachusetts
- +2 more
Jan 1, 2018
Renal Cell Carcinoma Trial in Boston (Electrofusion DC vaccine)
Completed
- Renal Cell Carcinoma
- Electrofusion DC vaccine
-
Boston, MassachusettsBIDMC
Mar 24, 2017
Renal Cell Carcinoma Trial in Boston (CT-011, DC/RCC fusion vaccine)
Terminated
- Renal Cell Carcinoma
- CT-011
- DC/RCC fusion vaccine
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Dec 15, 2016
Renal Cell Carcinoma Trial in Boston, Detroit (BKM-120 Bevacizumab)
Completed
- Renal Cell Carcinoma
- BKM-120 Bevacizumab
-
Boston, Massachusetts
- +2 more
Sep 19, 2016
Renal Cell Carcinoma, Tumor Metastases Trial in Boston (Gemcitabine, Sunitinib)
Completed
- Renal Cell Carcinoma
- Neoplasm Metastases
-
Boston, Massachusetts
- +2 more
Mar 23, 2016
Renal Cell Carcinoma, Metastases Trial in United States (Avastin (bevacizumab), Tarceva (erlotinib HCl))
Completed
- Renal Cell Carcinoma
- Metastases
- Avastin (bevacizumab)
- Tarceva (erlotinib HCl)
-
Concord, California
- +19 more
May 14, 2014
Papillary Thyroid Cancer, Follicular Thyroid Cancer, Huerthle Cell Thyroid Cancer Trial in United States (rosiglitazone, XL184)
Completed
- Papillary Thyroid Cancer
- +3 more
-
Duarte, California
- +4 more
Sep 17, 2013
Renal Cell Carcinoma Trial in Boston (Radiofrequency Ablation)
Withdrawn
- Renal Cell Carcinoma
- Radiofrequency Ablation
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Feb 26, 2013